Related Articles
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration
Vasohibin 1 inhibits Adriamycin resistance in osteosarcoma cells via the protein kinase B signaling pathway
MicroRNA‑4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma